Dr. Anatole Besarab MD

• 
  www.lyticmedicus.org/home.aspx - [Cached Version]
  Published on: 3/1/2005    Last Visited: 4/19/2007  

  Anatole BesarabNational Kidney FoundationHenry Ford Hospital

• 
  www.asdin.org/Visitors/About/officers.cfm?CFID=6968259& - [Cached Version]
  Published on: 7/25/2008    Last Visited: 7/25/2008  

  Anatole Besarab, MD - Detroit, MI (Hemodialysis Access Surveillance Technology)

• 
  www.lifesite.com/healthcare_professionals/hp_2.asp - [Cached Version]
  Published on: 3/9/2007    Last Visited: 3/9/2007  

  Anatole Besarab, MD, FACPDirector of ESRD ResearchDivision of Nephrology and HypertensionHenry Ford Hospital

• 
  www.lyticmedicus.org/faculty.aspx - [Cached Version]
  Published on: 4/19/2007    Last Visited: 4/19/2007  

  Anatole Besarab
  
  Chair, K/DOQI Vascular Access Work GroupSenior Staff, Director of Clinical ResearchDivision of Nephrology and Hypertension
  
  National Kidney Foundation

• 
  biz.yahoo.com/bw/070412/20070412005017.html?.v=1 - [Cached Version]
  Published on: 4/12/2007    Last Visited: 4/12/2007  

  The data were presented by Anatole Besarab, M.D., adjunct professor of Medicine, Wayne State University and director of Clinical Research at Henry Ford Hospital, Detroit in a poster session at the NKF meeting.
  
  "These data are encouraging and show that patients can be switched from a regimen of EPO three-times weekly to once monthly Hematide in a controlled fashion where hemoglobin levels were maintained within 1 g/dL of baseline at an appropriate dosing regimen," said Dr. Besarab.

• 
  www.affymax.com/pipeline_hematide.html - [Cached Version]
  Published on: 4/7/2006    Last Visited: 3/1/2007  

  Anatole Besarab, M.D.Henry Ford Hospital

• 
  www.healthsentinel.com/news.php?id=1848&title=Doctors+p - [Cached Version]
  Published on: 10/12/2008    Last Visited: 10/31/2007  

  Dr. Anatole Besarab of Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial.
  
  Some hospitals and doctors have used Epogen more conservatively than the big dialysis chains.

• 
  webssl.cancerdecisions.com/052007_page.html - [Cached Version]
  Published on: 5/20/2007    Last Visited: 9/27/2008  

  Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of that study, told the Times that Amgen and Johnson & Johnson had little incentive to conduct a definitive trial.

• 
  www.hdcn.com/symp/07asn/06/07asn06.htm - [Cached Version]
  Published on: 11/1/2007    Last Visited: 2/29/2008  

  Anatole Besarab, MD
  
  Discussion: Drive III.The Real World
  ...
  Anatole Besarab, MDHenry Ford Hospital

• 
  www.oasisadvancedwellness.com/learning/cancer-doctors-p - [Cached Version]
  Published on: 1/1/2007    Last Visited: 11/22/2007  

  Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of that study, told the Times that Amgen and Johnson & Johnson had little incentive to conduct a definitive trial.

Page:  1 2 3 4 5